Celgene CEO: We don't have to be No. 1 to thrive with new cancer therapy to replace chemo

"There's a lot of room for a lot of product to come in," Celgene chairman and CEO Mark Alles tells CNBC.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.